OcuNex (Telios Pharmaceuticals)

N/A

Report date: 2022/02/11 15:41:28
NME

Base Information

Drug NameOcuNex (Telios Pharmaceuticals)
Drug Alias NameOno 9001Ono-9001
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionIntegrin antagonists
TargetsIntegrin
Therapy Area/IndicationsCorneal Ulcer
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesIntegra Lifesciences
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesIntegra Lifesciences
Active IndicationsN/A
Inactive IndicationsCorneal Ulcer

Other Information

ATC CodeN/A
Related LinksN/A